Rare Variants in GJA5 Are Associated With Early-Onset Lone Atrial Fibrillation

Canadian Journal of Cardiology

Volumn 29, Issue 1, 2013, Pages 111-116

  Christophersen, Ingrid E ^a,b   Holmegard, Haya N ^a,b   Jabbari, Javad ^a,b   Haunsø, Stig ^a,b,c   Tveit, Arnljot ^d   Svendsen, Jesper H ^a,b,c   Olesen, Morten S ^a,b  

^a DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN; PROTEIN GJA5; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ALLELES; ATRIAL FIBRILLATION; CONFIDENCE INTERVALS; CONNEXINS; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HEART ATRIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORWAY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 84871435434     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.08.002     Document Type: Article

References (30)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
2. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
3. Page R.L., Wilkinson W.E., Clair W.K., McCarthy E.A., Pritchett E.L. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994, 89:224-227.
4. Israel C.W., Gronefeld G., Ehrlich J.R., Li Y.G., Hohnloser S.H. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 2004, 43:47-52.
5. Kannel W.B., Benjamin E.J. Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008, 92:17-40. ix.
6. Psaty B.M., Manolio T.A., Kuller L.H., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96:2455-2461.
7. Healey J.S., Parkash R., Pollak T., Tsang T., Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations. Can J Cardiol 2011, 27:31-37.
8. Potpara T.S., Lip G.Y. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract 2011, 65:446-457.
9. Olesen M.S., Bentzen B.H., Nielsen J.B., et al. Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet 2012, 13:24.
10. Olesen M.S., Yuan L., Liang B., et al. High prevalence of long QT syndrome associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet 2012, 5:450-459.
11. Olesen M.S., Holst A.G., Jabbari J., et al. Genetic loci on chromosomes 4q25, 7p31 and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years. Can J Cardiol 2012, 28:191-195.
12. Oyen N., Ranthe M.F., Carstensen L., et al. Familial aggregation of lone atrial fibrillation in young persons. J Am Coll Cardiol 2012, 60:917-921.
13. Sinner M.F., Ellinor P.T., Meitinger T., Benjamin E.J., Kaab S. Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res 2011, 89:701-709.
14. Olesen M.S., Jensen N.F., Holst A.G., et al. A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias [in English, French]. Can J Cardiol 2011, 27:523.e17-523.e23.
15. Chaldoupi S.M., Loh P., Hauer R.N., de Bakker J.M., van Rijen H.V. The role of connexin40 in atrial fibrillation. Cardiovasc Res 2009, 84:15-23.
16. Gollob M.H., Jones D.L., Krahn A.D., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006, 354:2677-2688.
17. Yang Y.Q., Zhang X.L., Wang X.H., et al. Connexin40 nonsense mutation in familial atrial fibrillation. Int J Mol Med 2010, 26:605-610.
18. Dupays L., Mazurais D., Rucker-Martin C., et al. Genomic organization and alternative transcripts of the human Connexin40 gene. Gene 2003, 305:79-90.
19. Wirka R.C., Gore S., Van Wagoner D.R., et al. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2011, 4:87-93.
20. Groenewegen W.A., Firouzi M., Bezzina C.R., et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 2003, 92:14-22.
21. Firouzi M., Ramanna H., Kok B., et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004, 95:e29-e33.
22. Juang J.M., Chern Y.R., Tsai C.T., et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007, 116:107-112.
23. Olesen M.S., Jespersen T., Nielsen J.B., et al. Mutations in sodium channel beta-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res 2011, 89:786-793.
24. Sajadieh A., Nielsen O.W., Rasmussen V., Hein H.O., Hansen J.F. Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2005, 26:1402-1409.
25. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073. The 1000 Genomes Project Consortium.
26. e!Ensembl. The Ensemble Genome Browser Website 2012. rs10465885 SNP Accessed June 28, 2012. http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core%3Br=1:147232240-147233240%3Bv=rs10465885%3Bvdb=variation%3Bvf=28132500.
27. Huang J., Ellinghaus D., Franke A., Howie B., Li Y. 1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data. Eur J Hum Genet 2012, 20:801-805.
28. Valiunas V., Gemel J., Brink P.R., Beyer E.C. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol 2001, 281:H1675-H1689.
29. Novembre J., Johnson T., Bryc K., et al. Genes mirror geography within Europe. Nature 2008, 456:98-101.
30. Cavalli-Sforza L.L., Menozzi P., Piazza A. The History and Geography of Human Genes 1996, Princeton University Press, Princeton, NJ.